Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors

JOURNAL ARTICLE published January 2020 in European Journal of Cancer

Research funded by National Taiwan University Hospital (NTUH 108-S4190,NTUH106-N3715) | National Taiwan University (NTU107L9014) | Ministry of Science and Technology, Taiwan (107-2314-B-002-275-MY3)

Authors: Ching-Yao Yang | Wei-Yu Liao | Chao-Chi Ho | Kuan-Yu Chen | Tzu-Hsiu Tsai | Chia-Lin Hsu | Kang-Yi Su | Yih-Leong Chang | Chen-Tu Wu | Chia-Chi Hsu | Bin-Chi Liao | Wei-Hsun Hsu | Jih-Hsiang Lee | Chia-Chi Lin | Jin-Yuan Shih | James C.-H. Yang | Chong-Jen Yu